Trial Profile
Evaluation of chromogranin A levels in patents with prostate cancer treated with enzalutamide.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Nov 2015
Price :
$35
*
At a glance
- Drugs Enzalutamide (Primary)
- Indications Prostate cancer
- Focus Adverse reactions; Therapeutic Use
- 18 Nov 2015 New trial record